Healio (1/14, Tedesco) reports, “Patients with young-onset type 2 diabetes have excess hospitalizations and a substantial mental illness burden before age 40 years,” researchers concluded after calculating “the all-cause and cause-specific hospitalization rates of a population-based cohort and registry-based cohort, including a total of 443,794 patients aged 20 to 75 years from Hong Kong, using the Hong Kong Diabetes Registry.”

MedPage Today (1/14, Monaco) reports that “after age 60, cardiovascular disease overtook mental health as the largest driver of hospitalizations, regardless of the onset age of diabetes.” Prior to age 40, “mental illness accounted for nearly 37% of all bed-days for those with young-onset diabetes.” The findings were published online Jan. 15 in the Annals of Internal Medicine. Medscape (1/14, Tucker, Subscription Publication) also covers the study.

Related Links:

— “Young-onset diabetes linked to increased risk for hospitalization, mental illness, “Alaina Tedesco, Healio, January 14, 2019

Medscape (1/14, Brooks, Subscription Publication) reports that after “analyzing data on 4,322 adults,” investigators “have identified five novel subtypes of insomnia, which may lead to more personalized treatments for insomnia.” According to Medscape, these “subtypes are largely unrelated to sleep complaints but rather are differentiated by biologically based traits and life history.” What’s more, the subtypes “are stable over time and are associated with comorbid depression, treatment responses, and findings in encephalographic event–related potentials, the investigators” found. The findings were published online Jan. 7 in The Lancet Psychiatry. The author of an accompanying commentary observed the study “suggests that ‘robust subtyping is possible among a population with insomnia.’”

Related Links:

— Medscape (requires login and subscription)

MD Magazine (1/11, Lutz) reported, “Psychiatric disorders and substance use disorders might reduce the efficacy of antiepileptic” medicines “among patients with epilepsy,” researches concluded after analyzing “data searching for treatment success and comorbid psychiatric diseases, including anxiety, schizophrenia, depression, and bipolar disorder, or substance use disorder including the use of substances, opioids, or cannabis.” The findings of the “more than 175,000”-patient study were presented American Epilepsy Society’s recent annual meeting.

Related Links:

— “Substance Use Disorder Reduces Antiepileptic Medication Success, “Rachel Lutz, MD Magazine, January 11, 2019

MedPage Today (1/14) reports a study funded by the NIH that included a survey of over 5,000 teen-parent pairs suggests that “parents were frequently unaware when their adolescent children had suicidal or morbid thoughts, but when they did believe their children thought about killing themselves, children often denied it.” The findings were published in Pediatrics.

Related Links:

— MedPage (requires login and subscription)

Healio (1/11, Demko) reported researchers found that in a “prospective cohort study” involving 34,552 children, “more than 40% started school with vulnerabilities in social-emotional functioning tied to emerging” mental illnesses. The findings were published online Jan. 4 in JAMA Network Open.

Related Links:

— “Many children may start school with social-emotional vulnerabilities, “Savannah Demko, Healio, January 11, 2019